Skip to content
10-Q

Quarterly Report

WEREWOLF THERAPEUTICS, INC. HOWL

0001785530-25-000014

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 44.87M sh
Capex Q1 2025 · Mar 31, 2025 $0
Capex Q1 2025 · Mar 31, 2024 $111K
Long Term Debt Q1 2025 · Mar 31, 2025 $32.09M
Current Liabilities Q1 2025 · Mar 31, 2025 $11.67M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.18M
Total Liabilities Q1 2025 · Mar 31, 2025 $49.93M
Total Liabilities Q1 2025 · Dec 31, 2024 $53.54M
Current Assets Q1 2025 · Mar 31, 2025 $94.46M
Current Assets Q1 2025 · Dec 31, 2024 $113.07M
Total Assets Q1 2025 · Mar 31, 2025 $107.24M
Total Assets Q1 2025 · Dec 31, 2024 $126.93M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $111M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $139.19M
Shares Diluted Q1 2025 · Mar 31, 2024 41.61M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$15.3M
Stockholders Equity Q1 2025 · Mar 31, 2024 $117.59M
Stockholders Equity Q1 2025 · Dec 31, 2023 $111.37M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.39
Eps Basic Q1 2025 · Mar 31, 2024 −$0.39
Sga Expense Q1 2025 · Mar 31, 2024 $5M
Rd Expense Q1 2025 · Mar 31, 2024 $12.91M
Net Income Q1 2025 · Mar 31, 2024 −$16.19M
Operating Income Q1 2025 · Mar 31, 2024 −$17.16M